找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: New Therapies in Advanced Cutaneous Malignancies; Piotr Rutkowski,Mario Mandalà Book 2021 The Editor(s) (if applicable) and The Author(s),

[复制链接]
查看: 16142|回复: 53
发表于 2025-3-21 19:55:31 | 显示全部楼层 |阅读模式
书目名称New Therapies in Advanced Cutaneous Malignancies
编辑Piotr Rutkowski,Mario Mandalà
视频video
概述Provides an in-depth description of the landscape of treatment building on the molecular and immunological characterization of the tumours, covering the current clinical scenario and looking to the fu
图书封面Titlebook: New Therapies in Advanced Cutaneous Malignancies;  Piotr Rutkowski,Mario Mandalà Book 2021 The Editor(s) (if applicable) and The Author(s),
描述.This book provides a detailed overview of the activity and efficacy of new treatments and promising perspectives in the field of cutaneous malignancies. The first part of the book covers the basic molecular and immunological mechanisms. It then goes on to cover specific strategies in melanoma and non-melanoma skin cancers that, starting from the basic mechanisms, translate this information into clinical routine or translational research. ..This unique handbook comprises very practical structured descriptions of more than 10 new agents used in treatment of melanomas and skin carcinomas together with biological background of their mechanisms of action. It provides structured and up-to-date information about all therapeutics in cutaneous malignancies, making it extremely useful in clinical practice, for clinicians that need timely and focused information. ..Prepared by a group of international authors from expert melanoma centres in Europe, the book provides knowledge distilled from the diverse perspectives of the contributing authors (pathologists, translational scientists and clinicians). This book is of interest to medical oncologists, oncological surgeons, dermatologists and immu
出版日期Book 2021
关键词melanoma; basal cell carcinoma; squamous cell carcinoma; Merkel cell carcinoma; immunotherapy; BRAF and M
版次1
doihttps://doi.org/10.1007/978-3-030-64009-5
isbn_softcover978-3-030-64011-8
isbn_ebook978-3-030-64009-5
copyrightThe Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerl
The information of publication is updating

书目名称New Therapies in Advanced Cutaneous Malignancies影响因子(影响力)




书目名称New Therapies in Advanced Cutaneous Malignancies影响因子(影响力)学科排名




书目名称New Therapies in Advanced Cutaneous Malignancies网络公开度




书目名称New Therapies in Advanced Cutaneous Malignancies网络公开度学科排名




书目名称New Therapies in Advanced Cutaneous Malignancies被引频次




书目名称New Therapies in Advanced Cutaneous Malignancies被引频次学科排名




书目名称New Therapies in Advanced Cutaneous Malignancies年度引用




书目名称New Therapies in Advanced Cutaneous Malignancies年度引用学科排名




书目名称New Therapies in Advanced Cutaneous Malignancies读者反馈




书目名称New Therapies in Advanced Cutaneous Malignancies读者反馈学科排名




单选投票, 共有 0 人参与投票
 

0票 0%

Perfect with Aesthetics

 

0票 0%

Better Implies Difficulty

 

0票 0%

Good and Satisfactory

 

0票 0%

Adverse Performance

 

0票 0%

Disdainful Garbage

您所在的用户组没有投票权限
发表于 2025-3-21 22:15:23 | 显示全部楼层
发表于 2025-3-22 02:15:29 | 显示全部楼层
发表于 2025-3-22 07:53:55 | 显示全部楼层
Sonidegibn the EU and additionally for patients who have recurred following surgery or radiation therapy in the United States. The efficacy and safety of sonidegib have been demonstrated in phase I and phase II clinical trials.
发表于 2025-3-22 10:58:13 | 显示全部楼层
Nivolumab in Melanoma: An Overview of Medical Literature and Future Perspectivesment of stage IIIB–IIIC/stage IV melanoma in 2017 on the basis of an improvement in recurrence-free survival versus the active comparator ipilimumab. In this chapter, we review the activity, efficacy, and toxicity of nivolumab and summarize new potential therapeutic strategies, which could potentially expand its spectrum of activity in melanoma.
发表于 2025-3-22 13:11:12 | 显示全部楼层
发表于 2025-3-22 20:03:18 | 显示全部楼层
发表于 2025-3-22 22:35:10 | 显示全部楼层
发表于 2025-3-23 04:08:45 | 显示全部楼层
Pathology of Melanoma and Skin Carcinomasial role in patient management and prognosis. Cutaneous melanomas, together with carcinomas, represent a majority of skin neoplasms. We have based this chapter on the fourth edition of the World Health Organization classification of Skin Tumours, published in 2018. The development of each malignancy
发表于 2025-3-23 09:08:11 | 显示全部楼层
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-5-18 10:14
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表